Liposomes are a critical tool to making supplements more efficacious, and ingredient supplier Specnova is at the forefront of liposomal innovation.

Liposomes can encapsulate and release small molecules and drugs to target specific parts in the body. Specnova CEO Sebastian Balcombe said his company can load 70% of the liposome and has the capacity to validate and characterize liposomes “much deeper than what’s done in the industry.” Watch the interview!

Interview by Claudia Adrien for NutraIngredients USA, November 12, 2024

Click on the link or the image to watch the Interview.
https://www.nutraingredients-usa.com/Article/2024/11/12/specnova-ceo-how-does-bioavailability-equate-to-efficacy-it-might-not./?cid=DM1170719&bid=550135357